RetinalGeniX Technologies, Inc. operates as a medical device company. Its products include the RetinalGeniXTM Imaging System, a diabetic non-mydriatic mass retinal imaging and screening device, and RetinalCamTM, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was founded by Erhan Gunday in November 2017 and is headquartered in Petaluma, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company